952664-68-5 Usage
Uses
Used in Pharmaceutical Industry:
3-tert-butyl-1H-indol-5-amine is used as a pharmaceutical compound for its potential anticancer properties. It has been studied for its ability to target and inhibit the growth of cancer cells, making it a promising candidate for the development of new cancer therapies.
Used in Antimicrobial Applications:
3-tert-butyl-1H-indol-5-amine is used as an antimicrobial agent for its potential to combat various types of bacteria and other microorganisms. Its unique structure allows it to disrupt the cellular processes of these organisms, making it a valuable tool in the fight against antibiotic-resistant infections.
Used in Anti-inflammatory Applications:
3-tert-butyl-1H-indol-5-amine is used as an anti-inflammatory agent for its potential to reduce inflammation and alleviate symptoms associated with various inflammatory conditions. Its ability to modulate immune responses and target specific inflammatory pathways makes it a promising candidate for the development of new treatments for inflammatory diseases.
Used in Industrial Applications:
3-tert-butyl-1H-indol-5-amine is used in various industrial applications due to its enhanced stability and resistance to degradation. Its unique chemical properties make it suitable for use in the development of new materials, coatings, and other products that require stability and durability.
Check Digit Verification of cas no
The CAS Registry Mumber 952664-68-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,2,6,6 and 4 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 952664-68:
(8*9)+(7*5)+(6*2)+(5*6)+(4*6)+(3*4)+(2*6)+(1*8)=205
205 % 10 = 5
So 952664-68-5 is a valid CAS Registry Number.
952664-68-5Relevant academic research and scientific papers
Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases
-
, (2015/09/22)
The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.
COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES
-
, (2012/04/23)
The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.
Modulators of ATP-binding cassette transporters
-
Page/Page column 112; 119, (2008/06/13)
Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.
